SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN) -- Ignore unavailable to you. Want to Upgrade?

To: paul goldstein who wrote (3717)7/14/1998 9:08:00 PM
From: Judy Muldawer  Read Replies (1) | Respond to of 4342
 
Things have got to turn around for PRLN now that Paul has found his CAPS key! Congrats, Paul.

Judy



To: paul goldstein who wrote (3717)7/15/1998 7:36:00 AM
From: John H. Farro  Respond to of 4342
 
Paul, good thinking. I agree with you. Though the completion of full fledged trials and FDA approval for PRLN's cancer drug candidates could take three to five years, we should have preliminary results much sooner than that. The stock price will undoubtedly receive a major boost if those results are promising.

Robin


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News